国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Exploration of the Hematological Profile of Male Sprague-Dawley Rats after Chronic Administration of an Ayurvedic Formulation Punarnavasava (PRV) Used in Ascites Treatment

Md Atikur Rahman, Mohammad Tohidul Amin, Md. Abdul Aziz, Kaniz Fatema, Palash karmakar, Niloy Sen and M Shahabuddin Kabir Choudhuri

Punarnavasava (PRV) is a classical Ayurvedic preparation and is very popular in rural areas due to its usage in the treatment of ascites. This study was conducted to explore the hemotoxicological effect of PRV after chronic administrations for 45 days to male Sprague-Dawley rats. After the observations, there were statistically significant changes in Basophil and Lymphocyte count (p=0.020 and p=0.032 respectively) but showed negligible changes for other hematological parameters like RBC, Hemoglobin, Hematocrit, Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC), Erythrocyte sedimentation rate (ESR), etc. From these results, it can be concluded that PRV is less hemotoxic at higher doses and thus can be recommended to use safely in the treatment of ascites.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。